No Data
Cipher Pharmaceuticals Down 16% as Partner Moberg Pharma AB Provides Lower Than Expected Study Results
Cipher Pharmaceuticals Brief: Vice President, Finance Ryan Mailling Appointed as Chief Financial Officer
Cipher Pharmaceuticals Brief: Management Changes to Take Effect on August 10, 2024, Include CFO Bryan Jacobs to Transition to President, Focusing on U.S. Operations
Cipher Pharmaceuticals Inc.'s (TSE:CPH) 31% Gain Last Week Benefited Both Individual Investors Who Own 53% as Well as Insiders
Press Release: Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders
Earnings Call Summary | Cipher Pharmaceuticals Inc(CPHRF.US) Q1 2024 Earnings Conference
No Data